[恶性淋巴瘤放射治疗的进展]
[Progress of radiation therapy in malignant lymphomas].
作者信息
Kaneta K, Nakazawa N, Kawabata K, Hashida J, Kawaguchi T, Yamashita T
机构信息
Dept. of Radiotherapy, Cancer Institute Hospital.
出版信息
Gan No Rinsho. 1988 Apr;34(5):555-64.
Radiation therapy is keeping an important role on treating stage I, II and III A Hodgkin's disease. Several prognostic factors influencing treatment result were discovered recently even though patients conditions belong to the same stage. Owing to rapid progress of multi-anticancer drug chemotherapy, indication of radiotherapy of non-Hodgkin's lymphoma has become narrower than 10 years ago. However, radiotherapy is important to cure both stage I and early stage II non-Hodgkin's lymphoma with low or intermediate grade histological malignancy.
放射治疗在治疗Ⅰ、Ⅱ和ⅢA期霍奇金病方面一直发挥着重要作用。尽管患者病情处于同一阶段，但最近发现了几个影响治疗效果的预后因素。由于多抗癌药物化疗的迅速发展，非霍奇金淋巴瘤的放射治疗指征比10年前变窄了。然而，放射治疗对于治愈组织学恶性程度低或中等的Ⅰ期和早期Ⅱ期非霍奇金淋巴瘤很重要。
Zotero 插件